<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD with MathML3 v1.1 20151215//EN" "JATS-journalpublishing1-mathml3.dtd">
<article dtd-version="1.1" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id></journal-id>
            <issn></issn>
        </journal-meta>
        <article-meta>
            <title-group>
                <article-title></article-title>
            </title-group>
            <pub-date>
                <year></year>
            </pub-date>
        </article-meta>
    </front>
    <back>
        <ref-list>
            <ref id="b1">
                <label>1. </label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Oellerich</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Dasgupta</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <source>Personalized Immunosuppression in Transplantation: Role of Biomarker Monitoring and Therapeutic Drug Monitoring</source>. 
                    <publisher-loc>Waltham</publisher-loc>: 
                    <publisher-name>Elsevier</publisher-name>; 
                    <year>2016</year>. pp. 
                    <fpage>1</fpage>–
                    <lpage>51</lpage>.
                </mixed-citation>
            </ref>
            <ref id="b2">
                <label>2. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Azzi</surname>
                            <given-names>JR</given-names>
                        </name>, 
                        <name>
                            <surname>Sayegh</surname>
                            <given-names>MH</given-names>
                        </name>, 
                        <name>
                            <surname>Mallat</surname>
                            <given-names>SG</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Calcineurin inhibitors: 40 years later, can’t live without ...</article-title>. 
                    <source>J Immunol</source>. 
                    <year>2013</year>
                    <month>Dec</month>;
                    <volume>191</volume>(
                    <issue>12</issue>):
                    <fpage>5785</fpage>–
                    <lpage>91</lpage>. 
                    <pub-id pub-id-type="doi">10.4049/jimmunol.1390055</pub-id>
                    <pub-id pub-id-type="pmid">24319282</pub-id>
                    <issn>0022-1767</issn>
                </mixed-citation>
            </ref>
            <ref id="b3">
                <label>3. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Povzetek glavnih značilnosti zdravila Sandimmun Neoral</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>].
                    <comment>Available from:<uri>http://www.cbz.si/ZZZS/pao/bazazdr2.nsf/o/15F9EEB8ACC17C2AC12579C2003F5926/$File/s-015812.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b4">
                <label>4. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Podatkovna baza Micromedex: Cyclosporine</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.micromedexsolutions.com/home/dispatch</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b5">
                <label>5. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Barbarino</surname>
                            <given-names>JM</given-names>
                        </name>, 
                        <name>
                            <surname>Staatz</surname>
                            <given-names>CE</given-names>
                        </name>, 
                        <name>
                            <surname>Venkataramanan</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Klein</surname>
                            <given-names>TE</given-names>
                        </name>, 
                        <name>
                            <surname>Altman</surname>
                            <given-names>RB</given-names>
                        </name>
                    </person-group>. 
                    <article-title>PharmGKB summary: cyclosporine and tacrolimus pathways</article-title>. 
                    <source>Pharmacogenet Genomics</source>. 
                    <year>2013</year>
                    <month>Oct</month>;
                    <volume>23</volume>(
                    <issue>10</issue>):
                    <fpage>563</fpage>–
                    <lpage>85</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/FPC.0b013e328364db84</pub-id>
                    <pub-id pub-id-type="pmid">23922006</pub-id>
                    <issn>1744-6872</issn>
                </mixed-citation>
            </ref>
            <ref id="b6">
                <label>6. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Finch</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Pillans</surname>
                            <given-names>P</given-names>
                        </name>
                    </person-group>. 
                    <article-title>P-glycoprotein and its role in drug-drug interactions</article-title>. 
                    <source>Aust Prescr</source>. 
                    <year>2014</year>;
                    <volume>37</volume>(
                    <issue>4</issue>):
                    <fpage>137</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.18773/austprescr.2014.050</pub-id>
                    <issn>0312-8008</issn>
                </mixed-citation>
            </ref>
            <ref id="b7">
                <label>7. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zheng</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Tasnif</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Hebert</surname>
                            <given-names>MF</given-names>
                        </name>, 
                        <name>
                            <surname>Davis</surname>
                            <given-names>CL</given-names>
                        </name>, 
                        <name>
                            <surname>Shitara</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Calamia</surname>
                            <given-names>JC</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>CYP3A5 gene variation influences cyclosporine A metabolite formation and renal cyclosporine disposition</article-title>. 
                    <source>Transplantation</source>. 
                    <year>2013</year>
                    <month>Mar</month>;
                    <volume>95</volume>(
                    <issue>6</issue>):
                    <fpage>821</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/TP.0b013e31827e6ad9</pub-id>
                    <pub-id pub-id-type="pmid">23354298</pub-id>
                    <issn>0041-1337</issn>
                </mixed-citation>
            </ref>
            <ref id="b8">
                <label>8. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zhu</surname>
                            <given-names>HJ</given-names>
                        </name>, 
                        <name>
                            <surname>Yuan</surname>
                            <given-names>SH</given-names>
                        </name>, 
                        <name>
                            <surname>Fang</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Sun</surname>
                            <given-names>XZ</given-names>
                        </name>, 
                        <name>
                            <surname>Kong</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Ge</surname>
                            <given-names>WH</given-names>
                        </name>
                    </person-group>. 
                    <article-title>The effect of CYP3A5 polymorphism on dose-adjusted cyclosporine concentration in renal transplant recipients: a meta-analysis</article-title>. 
                    <source>Pharmacogenomics J</source>. 
                    <year>2011</year>
                    <month>Jun</month>;
                    <volume>11</volume>(
                    <issue>3</issue>):
                    <fpage>237</fpage>–
                    <lpage>46</lpage>. 
                    <pub-id pub-id-type="doi">10.1038/tpj.2010.26</pub-id>
                    <pub-id pub-id-type="pmid">20368718</pub-id>
                    <issn>1470-269X</issn>
                </mixed-citation>
            </ref>
            <ref id="b9">
                <label>9. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Maezono</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Sugimoto</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Sakamoto</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Ohmori</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Hishikawa</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Mizuta</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Elevated blood concentrations of calcineurin inhibitors during diarrheal episode in pediatric liver transplant recipients: involvement of the suppression of intestinal cytochrome P450 3A and P-glycoprotein</article-title>. 
                    <source>Pediatr Transplant</source>. 
                    <year>2005</year>
                    <month>Jun</month>;
                    <volume>9</volume>(
                    <issue>3</issue>):
                    <fpage>315</fpage>–
                    <lpage>23</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1399-3046.2005.00315.x</pub-id>
                    <pub-id pub-id-type="pmid">15910387</pub-id>
                    <issn>1397-3142</issn>
                </mixed-citation>
            </ref>
            <ref id="b10">
                <label>10. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Podatkovna baza UpToDate: Cyclosporine</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>https://www.uptodate.com/contents/search</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b11">
                <label>11. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kiani</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Imam</surname>
                            <given-names>SZ</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Medicinal importance of grapefruit juice and its interaction with various drugs</article-title>. 
                    <source>Nutr J</source>. 
                    <year>2007</year>
                    <month>Oct</month>;
                    <volume>6</volume>(
                    <issue>1</issue>):
                    <fpage>33</fpage>. 
                    <pub-id pub-id-type="doi">10.1186/1475-2891-6-33</pub-id>
                    <pub-id pub-id-type="pmid">17971226</pub-id>
                    <issn>1475-2891</issn>
                </mixed-citation>
            </ref>
            <ref id="b12">
                <label>12. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Colombo</surname>
                            <given-names>D</given-names>
                        </name>, 
                        <name>
                            <surname>Lunardon</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Bellia</surname>
                            <given-names>G</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Cyclosporine and herbal supplement interactions</article-title>. 
                    <source>J Toxicol</source>. 
                    <year>2014</year>;
                    <volume>2014</volume>:
                    <fpage>145325</fpage>. 
                    <pub-id pub-id-type="doi">10.1155/2014/145325</pub-id>
                    <pub-id pub-id-type="pmid">24527031</pub-id>
                    <issn>1687-8191</issn>
                </mixed-citation>
            </ref>
            <ref id="b13">
                <label>13. </label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name>
                            <surname>West</surname>
                            <given-names>SG</given-names>
                        </name>
                    </person-group>. 
                    <source>Rheumatology Secrets</source>. 
                    <publisher-loc>Philadelphia</publisher-loc>: 
                    <publisher-name>Elsevier</publisher-name>; 
                    <year>2015</year>. pp. 
                    <fpage>627</fpage>–
                    <lpage>32</lpage>.
                </mixed-citation>
            </ref>
            <ref id="b14">
                <label>14. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Russo</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Scicchitano</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Whalley</surname>
                            <given-names>BJ</given-names>
                        </name>, 
                        <name>
                            <surname>Mazzitello</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Ciriaco</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Esposito</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Hypericum perforatum: pharmacokinetic, mechanism of action, tolerability, and clinical drug-drug interactions</article-title>. 
                    <source>Phytother Res</source>. 
                    <year>2014</year>
                    <month>May</month>;
                    <volume>28</volume>(
                    <issue>5</issue>):
                    <fpage>643</fpage>–
                    <lpage>55</lpage>. 
                    <pub-id pub-id-type="doi">10.1002/ptr.5050</pub-id>
                    <pub-id pub-id-type="pmid">23897801</pub-id>
                    <issn>0951-418X</issn>
                </mixed-citation>
            </ref>
            <ref id="b15">
                <label>15. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Harris</surname>
                            <given-names>RZ</given-names>
                        </name>, 
                        <name>
                            <surname>Jang</surname>
                            <given-names>GR</given-names>
                        </name>, 
                        <name>
                            <surname>Tsunoda</surname>
                            <given-names>S</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Dietary effects on drug metabolism and transport</article-title>. 
                    <source>Clin Pharmacokinet</source>. 
                    <year>2003</year>;
                    <volume>42</volume>(
                    <issue>13</issue>):
                    <fpage>1071</fpage>–
                    <lpage>88</lpage>. 
                    <pub-id pub-id-type="doi">10.2165/00003088-200342130-00001</pub-id>
                    <pub-id pub-id-type="pmid">14531721</pub-id>
                    <issn>0312-5963</issn>
                </mixed-citation>
            </ref>
            <ref id="b16">
                <label>16. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Fujita</surname>
                            <given-names>K</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Food-drug interactions via human cytochrome P450 3A (CYP3A)</article-title>. 
                    <source>Drug Metabol Drug Interact</source>. 
                    <year>2004</year>;
                    <volume>20</volume>(
                    <issue>4</issue>):
                    <fpage>195</fpage>–
                    <lpage>217</lpage>. 
                    <pub-id pub-id-type="doi">10.1515/DMDI.2004.20.4.195</pub-id>
                    <pub-id pub-id-type="pmid">15663291</pub-id>
                    <issn>0792-5077</issn>
                </mixed-citation>
            </ref>
            <ref id="b17">
                <label>17. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tsunoda</surname>
                            <given-names>SM</given-names>
                        </name>, 
                        <name>
                            <surname>Harris</surname>
                            <given-names>RZ</given-names>
                        </name>, 
                        <name>
                            <surname>Christians</surname>
                            <given-names>U</given-names>
                        </name>, 
                        <name>
                            <surname>Velez</surname>
                            <given-names>RL</given-names>
                        </name>, 
                        <name>
                            <surname>Freeman</surname>
                            <given-names>RB</given-names>
                        </name>, 
                        <name>
                            <surname>Benet</surname>
                            <given-names>LZ</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Red wine decreases cyclosporine bioavailability</article-title>. 
                    <source>Clin Pharmacol Ther</source>. 
                    <year>2001</year>
                    <month>Nov</month>;
                    <volume>70</volume>(
                    <issue>5</issue>):
                    <fpage>462</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0009-9236(01)70992-7</pub-id>
                    <pub-id pub-id-type="pmid">11719733</pub-id>
                    <issn>0009-9236</issn>
                </mixed-citation>
            </ref>
            <ref id="b18">
                <label>18. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Vari</surname>
                            <given-names>CE</given-names>
                        </name>, 
                        <name>
                            <surname>Tero-Vescan</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Imre</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Muntean</surname>
                            <given-names>DL</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Therapeutic Drug Monitoring of Cyclosporine in Transplanted Patients. Possibilities, Controversy, Causes for Failure</article-title>. 
                    <source>Farmacia</source>. 
                    <year>2012</year>;
                    <volume>60</volume>:
                    <fpage>595</fpage>–
                    <lpage>601</lpage>.
                    <issn>0014-8237</issn>
                </mixed-citation>
            </ref>
            <ref id="b19">
                <label>19. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Jorga</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Holt</surname>
                            <given-names>DW</given-names>
                        </name>, 
                        <name>
                            <surname>Johnston</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Therapeutic drug monitoring of cyclosporine</article-title>. 
                    <source>Transplant Proc</source>. 
                    <year>2004</year>
                    <month>Mar</month>;
                    <volume>36</volume>(
                    <issue>2</issue>
                    <supplement>Suppl</supplement>):
                    <fpage>396S</fpage>–
                    <lpage>403S</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.transproceed.2004.01.013</pub-id>
                    <pub-id pub-id-type="pmid">15041374</pub-id>
                    <issn>0041-1345</issn>
                </mixed-citation>
            </ref>
            <ref id="b20">
                <label>20. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Citterio</surname>
                            <given-names>F</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Evolution of the therapeutic drug monitoring of cyclosporine</article-title>. 
                    <source>Transplant Proc</source>. 
                    <year>2004</year>
                    <month>Mar</month>;
                    <volume>36</volume>(
                    <issue>2</issue>
                    <supplement>Suppl</supplement>):
                    <fpage>420S</fpage>–
                    <lpage>5S</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.transproceed.2004.01.054</pub-id>
                    <pub-id pub-id-type="pmid">15041378</pub-id>
                    <issn>0041-1345</issn>
                </mixed-citation>
            </ref>
            <ref id="b21">
                <label>21. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Büchler</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Johnston</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Seeking optimal prescription of cyclosporine ME</article-title>. 
                    <source>Ther Drug Monit</source>. 
                    <year>2005</year>
                    <month>Feb</month>;
                    <volume>27</volume>(
                    <issue>1</issue>):
                    <fpage>3</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1097/00007691-200502000-00002</pub-id>
                    <pub-id pub-id-type="pmid">15665738</pub-id>
                    <issn>0163-4356</issn>
                </mixed-citation>
            </ref>
            <ref id="b22">
                <label>22. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Einecke</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Mai</surname>
                            <given-names>I</given-names>
                        </name>, 
                        <name>
                            <surname>Diekmann</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Fritsche</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Boehler</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Neumayer</surname>
                            <given-names>HH</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Optimizing Neoral therapeutic drug monitoring with cyclosporine trough (C(
                        <sub>0</sub>)) and C(
                        <sub>2</sub>) concentrations in stable renal allograft recipients
                    </article-title>. 
                    <source>Transplant Proc</source>. 
                    <year>2001</year>
                    <month>Nov-Dec</month>;
                    <volume>33</volume>(
                    <issue>7-8</issue>):
                    <fpage>3102</fpage>–
                    <lpage>3</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0041-1345(01)02322-3</pub-id>
                    <pub-id pub-id-type="pmid">11750333</pub-id>
                    <issn>0041-1345</issn>
                </mixed-citation>
            </ref>
            <ref id="b23">
                <label>23. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Durlik</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Rauch</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Thyroff-Friesinger</surname>
                            <given-names>U</given-names>
                        </name>, 
                        <name>
                            <surname>Streu</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Paczek</surname>
                            <given-names>L</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Comparison of peak and trough level monitoring of cyclosporine treatment using two modern cyclosporine preparations</article-title>. 
                    <source>Transplant Proc</source>. 
                    <year>2003</year>
                    <month>Jun</month>;
                    <volume>35</volume>(
                    <issue>4</issue>):
                    <fpage>1304</fpage>–
                    <lpage>7</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0041-1345(03)00516-5</pub-id>
                    <pub-id pub-id-type="pmid">12826144</pub-id>
                    <issn>0041-1345</issn>
                </mixed-citation>
            </ref>
            <ref id="b24">
                <label>24. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Maziers</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Bulpa</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Jamart</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Delaunois</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Eucher</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Evrard</surname>
                            <given-names>P</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Correlations between cyclosporine concentrations at 2 hours post-dose and trough levels with functional outcomes in de novo lung transplant recipients</article-title>. 
                    <source>Transplant Proc</source>. 
                    <year>2012</year>
                    <month>Nov</month>;
                    <volume>44</volume>(
                    <issue>9</issue>):
                    <fpage>2880</fpage>–
                    <lpage>4</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.transproceed.2012.09.081</pub-id>
                    <pub-id pub-id-type="pmid">23146546</pub-id>
                    <issn>0041-1345</issn>
                </mixed-citation>
            </ref>
            <ref id="b25">
                <label>25. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Saint-Marcoux</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Rousseau</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Le Meur</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Estenne</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Knoop</surname>
                            <given-names>C</given-names>
                        </name>, 
                        <name>
                            <surname>Debord</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Influence of sampling-time error on cyclosporine measurements nominally at 2 hours after administration</article-title>. 
                    <source>Clin Chem</source>. 
                    <year>2003</year>
                    <month>May</month>;
                    <volume>49</volume>(
                    <issue>5</issue>):
                    <fpage>813</fpage>–
                    <lpage>5</lpage>. 
                    <pub-id pub-id-type="doi">10.1373/49.5.813</pub-id>
                    <pub-id pub-id-type="pmid">12709377</pub-id>
                    <issn>0009-9147</issn>
                </mixed-citation>
            </ref>
            <ref id="b26">
                <label>26. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wacke</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Drewelow</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Kundt</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Hehl</surname>
                            <given-names>EM</given-names>
                        </name>, 
                        <name>
                            <surname>Bast</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Seiter</surname>
                            <given-names>H</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Cyclosporine A: peak or trough level monitoring in renal transplant recipients?</article-title>
                    <source>Transplant Proc</source>. 
                    <year>2001</year>
                    <month>Nov-Dec</month>;
                    <volume>33</volume>(
                    <issue>7-8</issue>):
                    <fpage>3122</fpage>–
                    <lpage>3</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/S0041-1345(01)02331-4</pub-id>
                    <pub-id pub-id-type="pmid">11750342</pub-id>
                    <issn>0041-1345</issn>
                </mixed-citation>
            </ref>
            <ref id="b27">
                <label>27. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Clinical Laboratory Medicine: Cyclosporin A</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://pathlabs.rlbuht.nhs.uk/overfrm.htm</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b28">
                <label>28. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tesfaye</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Prusa</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Jedlickova</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Segethova</surname>
                            <given-names>J</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?</article-title>
                    <source>Ann Transplant</source>. 
                    <year>2008</year>;
                    <volume>13</volume>(
                    <issue>4</issue>):
                    <fpage>34</fpage>–
                    <lpage>40</lpage>.
                    <pub-id pub-id-type="pmid">19034221</pub-id>
                    <issn>1425-9524</issn>
                </mixed-citation>
            </ref>
            <ref id="b29">
                <label>29. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ekberg</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Tedesco-Silva</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Demirbas</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Vítko</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Nashan</surname>
                            <given-names>B</given-names>
                        </name>, 
                        <name>
                            <surname>Gürkan</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>ELITE-Symphony Study</collab>
                    </person-group>. 
                    <article-title>Reduced exposure to calcineurin inhibitors in renal transplantation</article-title>. 
                    <source>N Engl J Med</source>. 
                    <year>2007</year>
                    <month>Dec</month>;
                    <volume>357</volume>(
                    <issue>25</issue>):
                    <fpage>2562</fpage>–
                    <lpage>75</lpage>. 
                    <pub-id pub-id-type="doi">10.1056/NEJMoa067411</pub-id>
                    <pub-id pub-id-type="pmid">18094377</pub-id>
                    <issn>0028-4793</issn>
                </mixed-citation>
            </ref>
            <ref id="b30">
                <label>30. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schiff</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Cole</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Cantarovich</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Therapeutic monitoring of calcineurin inhibitors for the nephrologist</article-title>. 
                    <source>Clin J Am Soc Nephrol</source>. 
                    <year>2007</year>
                    <month>Mar</month>;
                    <volume>2</volume>(
                    <issue>2</issue>):
                    <fpage>374</fpage>–
                    <lpage>84</lpage>. 
                    <pub-id pub-id-type="doi">10.2215/CJN.03791106</pub-id>
                    <pub-id pub-id-type="pmid">17699437</pub-id>
                    <issn>1555-9041</issn>
                </mixed-citation>
            </ref>
            <ref id="b31">
                <label>31. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ytterberg</surname>
                            <given-names>SR</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Treatment of refractory polymyositis and dermatomyositis</article-title>. 
                    <source>Curr Rheumatol Rep</source>. 
                    <year>2006</year>
                    <month>Jun</month>;
                    <volume>8</volume>(
                    <issue>3</issue>):
                    <fpage>167</fpage>–
                    <lpage>73</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s11926-996-0021-7</pub-id>
                    <pub-id pub-id-type="pmid">16901073</pub-id>
                    <issn>1523-3774</issn>
                </mixed-citation>
            </ref>
            <ref id="b32">
                <label>32. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ogawa</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Kameda</surname>
                            <given-names>H</given-names>
                        </name>, 
                        <name>
                            <surname>Amano</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Takeuchi</surname>
                            <given-names>T</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Efficacy and safety of cyclosporine A in patients with refractory systemic lupus erythematosus in a daily clinical practice</article-title>. 
                    <source>Lupus</source>. 
                    <year>2010</year>
                    <month>Feb</month>;
                    <volume>19</volume>(
                    <issue>2</issue>):
                    <fpage>162</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1177/0961203309350320</pub-id>
                    <pub-id pub-id-type="pmid">19952069</pub-id>
                    <issn>0961-2033</issn>
                </mixed-citation>
            </ref>
            <ref id="b33">
                <label>33. </label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tsokos</surname>
                            <given-names>GC</given-names>
                        </name>
                    </person-group>. 
                    <source>Systemic Lupus Erythematosus: Basic, Applied and Clinical Aspects</source>. 
                    <publisher-loc>San Diego</publisher-loc>: 
                    <publisher-name>Elsevier</publisher-name>; 
                    <year>2016</year>. pp. 
                    <fpage>533</fpage>–
                    <lpage>9</lpage>.
                </mixed-citation>
            </ref>
            <ref id="b34">
                <label>34. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chi</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Yang</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Zhu</surname>
                            <given-names>X</given-names>
                        </name>, 
                        <name>
                            <surname>Wang</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <name>
                            <surname>Chen</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Huang</surname>
                            <given-names>X</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Production of interleukin-17 in Behcet’s disease is inhibited by cyclosporin A</article-title>. 
                    <source>Mol Vis</source>. 
                    <year>2010</year>
                    <month>May</month>;
                    <volume>16</volume>:
                    <fpage>880</fpage>–
                    <lpage>6</lpage>.
                    <pub-id pub-id-type="pmid">20508866</pub-id>
                    <issn>1090-0535</issn>
                </mixed-citation>
            </ref>
            <ref id="b35">
                <label>35. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <collab>Cyclosporine Clinic</collab>
                    </person-group>. 
                    <source>Guidelines For Monitoring Physicians</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://mpap.vch.ca/wp-content/uploads/sites/16/2014/05/Cyclosporine-Physician-Guidelines.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b36">
                <label>36. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bergner</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Landmann</surname>
                            <given-names>T</given-names>
                        </name>, 
                        <name>
                            <surname>Tuleweit</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Abdel Mutallib</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Geibel</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Uppenkamp</surname>
                            <given-names>M</given-names>
                        </name>
                    </person-group>. 
                    <source>Ist die Bestimmung von Cyclosporin Spiegeln in der Rheumatologie erforderlich?</source>
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://dgrh-kongress.de/fileadmin/media/Die_DGRH/Jahreskongresse/Abstracts_2008_PDFs/K08_RA2.08.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b37">
                <label>37. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Waldman</surname>
                            <given-names>M</given-names>
                        </name>, 
                        <name>
                            <surname>Austin</surname>
                            <given-names>HA</given-names>
                            <suffix>3rd</suffix>
                        </name>
                    </person-group>. 
                    <article-title>Treatment of idiopathic membranous nephropathy</article-title>. 
                    <source>J Am Soc Nephrol</source>. 
                    <year>2012</year>
                    <month>Oct</month>;
                    <volume>23</volume>(
                    <issue>10</issue>):
                    <fpage>1617</fpage>–
                    <lpage>30</lpage>. 
                    <pub-id pub-id-type="doi">10.1681/ASN.2012010058</pub-id>
                    <pub-id pub-id-type="pmid">22859855</pub-id>
                    <issn>1046-6673</issn>
                </mixed-citation>
            </ref>
            <ref id="b38">
                <label>38. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Merlin</surname>
                            <given-names>T</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Membranous nephropathy: role of cyclosporin therapy</article-title>. 
                    <source>Nephrology (Carlton)</source>. 
                    <year>2006</year>;
                    <volume>11</volume>(
                    <issue>S1</issue>):
                    <fpage>S166</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1111/j.1440-1797.2006.00634.x</pub-id>
                    <issn>1320-5358</issn>
                    
                </mixed-citation>
            </ref>
            <ref id="b39">
                <label>39. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ghiggeri</surname>
                            <given-names>GM</given-names>
                        </name>, 
                        <name>
                            <surname>Catarsi</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Scolari</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Caridi</surname>
                            <given-names>G</given-names>
                        </name>, 
                        <name>
                            <surname>Bertelli</surname>
                            <given-names>R</given-names>
                        </name>, 
                        <name>
                            <surname>Carrea</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Cyclosporine in patients with steroid-resistant nephrotic syndrome: an open-label, nonrandomized, retrospective study</article-title>. 
                    <source>Clin Ther</source>. 
                    <year>2004</year>
                    <month>Sep</month>;
                    <volume>26</volume>(
                    <issue>9</issue>):
                    <fpage>1411</fpage>–
                    <lpage>8</lpage>. 
                    <pub-id pub-id-type="doi">10.1016/j.clinthera.2004.09.012</pub-id>
                    <pub-id pub-id-type="pmid">15531003</pub-id>
                    <issn>0149-2918</issn>
                </mixed-citation>
            </ref>
            <ref id="b40">
                <label>40. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gulati</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Bagga</surname>
                            <given-names>A</given-names>
                        </name>, 
                        <name>
                            <surname>Gulati</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Mehta</surname>
                            <given-names>KP</given-names>
                        </name>, 
                        <name>
                            <surname>Vijayakumar</surname>
                            <given-names>M</given-names>
                        </name>; 
                        <collab>Indian Society of Pediatric Nephrology</collab>
                    </person-group>. 
                    <article-title>Management of steroid resistant nephrotic syndrome</article-title>. 
                    <source>Indian Pediatr</source>. 
                    <year>2009</year>
                    <month>Jan</month>;
                    <volume>46</volume>(
                    <issue>1</issue>):
                    <fpage>35</fpage>–
                    <lpage>47</lpage>.
                    <pub-id pub-id-type="pmid">19179716</pub-id>
                    <issn>0019-6061</issn>
                </mixed-citation>
            </ref>
            <ref id="b41">
                <label>41. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Passweg</surname>
                            <given-names>JR</given-names>
                        </name>, 
                        <name>
                            <surname>Marsh</surname>
                            <given-names>JC</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Aplastic anemia: first-line treatment by immunosuppression and sibling marrow transplantation</article-title>. 
                    <source>Hematology (Am Soc Hematol Educ Program)</source>. 
                    <year>2010</year>;
                    <volume>2010</volume>(
                    <issue>1</issue>):
                    <fpage>36</fpage>–
                    <lpage>42</lpage>. 
                    <pub-id pub-id-type="doi">10.1182/asheducation-2010.1.36</pub-id>
                    <pub-id pub-id-type="pmid">21239768</pub-id>
                    <issn>1520-4391</issn>
                </mixed-citation>
            </ref>
            <ref id="b42">
                <label>42. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Murphy</surname>
                            <given-names>CC</given-names>
                        </name>, 
                        <name>
                            <surname>Greiner</surname>
                            <given-names>K</given-names>
                        </name>, 
                        <name>
                            <surname>Plskova</surname>
                            <given-names>J</given-names>
                        </name>, 
                        <name>
                            <surname>Duncan</surname>
                            <given-names>L</given-names>
                        </name>, 
                        <name>
                            <surname>Frost</surname>
                            <given-names>NA</given-names>
                        </name>, 
                        <name>
                            <surname>Forrester</surname>
                            <given-names>JV</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Cyclosporine vs tacrolimus therapy for posterior and intermediate uveitis</article-title>. 
                    <source>Arch Ophthalmol</source>. 
                    <year>2005</year>
                    <month>May</month>;
                    <volume>123</volume>(
                    <issue>5</issue>):
                    <fpage>634</fpage>–
                    <lpage>41</lpage>. 
                    <pub-id pub-id-type="doi">10.1001/archopht.123.5.634</pub-id>
                    <pub-id pub-id-type="pmid">15883282</pub-id>
                    <issn>0003-9950</issn>
                </mixed-citation>
            </ref>
            <ref id="b43">
                <label>43. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schmidt</surname>
                            <given-names>S</given-names>
                        </name>, 
                        <name>
                            <surname>Pleyer</surname>
                            <given-names>U</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Ciclosporin-Monitoring bei Patienten mit chronischer Uveitis</article-title>. 
                    <source>Ophthalmologe</source>. 
                    <year>2005</year>
                    <month>Apr</month>;
                    <volume>102</volume>(
                    <issue>4</issue>):
                    <fpage>349</fpage>–
                    <lpage>54</lpage>. 
                    <pub-id pub-id-type="doi">10.1007/s00347-005-1174-x</pub-id>
                    <pub-id pub-id-type="pmid">15726383</pub-id>
                    <issn>0941-293X</issn>
                </mixed-citation>
            </ref>
            <ref id="b44">
                <label>44. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Heydendael</surname>
                            <given-names>VM</given-names>
                        </name>, 
                        <name>
                            <surname>Spuls</surname>
                            <given-names>PI</given-names>
                        </name>, 
                        <name>
                            <surname>Ten Berge</surname>
                            <given-names>IJ</given-names>
                        </name>, 
                        <name>
                            <surname>Opmeer</surname>
                            <given-names>BC</given-names>
                        </name>, 
                        <name>
                            <surname>Bos</surname>
                            <given-names>JD</given-names>
                        </name>, 
                        <name>
                            <surname>de Rie</surname>
                            <given-names>MA</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Cyclosporin trough levels: is monitoring necessary during short-term treatment in psoriasis? A systematic review and clinical data on trough levels</article-title>. 
                    <source>Br J Dermatol</source>. 
                    <year>2002</year>
                    <month>Jul</month>;
                    <volume>147</volume>(
                    <issue>1</issue>):
                    <fpage>122</fpage>–
                    <lpage>9</lpage>. 
                    <pub-id pub-id-type="doi">10.1046/j.1365-2133.2002.04836.x</pub-id>
                    <pub-id pub-id-type="pmid">12100194</pub-id>
                    <issn>0007-0963</issn>
                </mixed-citation>
            </ref>
            <ref id="b45">
                <label>45. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Focal segmental glomerulosclerosis: use of cyclosporin A. The CARI Guidelines – Caring for Australasians with Renal Impairment</source>. 
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-15">cited 2019 Mar 15</date-in-citation>].
                    <comment>Available from:<uri>http://www.cari.org.au/Archived%20guidelines/CKD%20archived/prevention%20of%20progression/FSGS_use_of_cyclosporin_A.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b46">
                <label>46. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cattran</surname>
                            <given-names>DC</given-names>
                        </name>, 
                        <name>
                            <surname>Appel</surname>
                            <given-names>GB</given-names>
                        </name>, 
                        <name>
                            <surname>Hebert</surname>
                            <given-names>LA</given-names>
                        </name>, 
                        <name>
                            <surname>Hunsicker</surname>
                            <given-names>LG</given-names>
                        </name>, 
                        <name>
                            <surname>Pohl</surname>
                            <given-names>MA</given-names>
                        </name>, 
                        <name>
                            <surname>Hoy</surname>
                            <given-names>WE</given-names>
                        </name>, 
                        <etal>et al</etal>; 
                        <collab>North America Nephrotic Syndrome Study Group</collab>
                    </person-group>. 
                    <article-title>A randomized trial of cyclosporine in patients with steroid-resistant focal segmental glomerulosclerosis</article-title>. 
                    <source>Kidney Int</source>. 
                    <year>1999</year>
                    <month>Dec</month>;
                    <volume>56</volume>(
                    <issue>6</issue>):
                    <fpage>2220</fpage>–
                    <lpage>6</lpage>. 
                    <pub-id pub-id-type="doi">10.1046/j.1523-1755.1999.00778.x</pub-id>
                    <pub-id pub-id-type="pmid">10594798</pub-id>
                    <issn>0085-2538</issn>
                </mixed-citation>
            </ref>
            <ref id="b47">
                <label>47. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Guidelines for the diagnosis and treatment of Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia. Nordic MDS Group</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2019-03-15">cited 2019 Mar 15</date-in-citation>].
                    <comment>Available from:<uri>https://www.nmds.org/attachments/article/92/Guidelines%20for%20the%20diagnosis%20and%20treatment%20of%20MDS%20and%20CMML_17.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b48">
                <label>48. </label>
                <mixed-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Clarke</surname>
                            <given-names>W</given-names>
                        </name>, 
                        <name>
                            <surname>Dasgupta</surname>
                            <given-names>A</given-names>
                        </name>
                    </person-group>. 
                    <source>Clinical Challenges in Therapeutic Drug Monitoring</source>. 
                    <publisher-loc>Oxford</publisher-loc>: 
                    <publisher-name>Elsevier</publisher-name>; 
                    <year>2016</year>.
                </mixed-citation>
            </ref>
            <ref id="b49">
                <label>49. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Morris</surname>
                            <given-names>RG</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Cyclosporin therapeutic drug monitoring—an established service revisited</article-title>. 
                    <source>Clin Biochem Rev</source>. 
                    <year>2003</year>
                    <month>May</month>;
                    <volume>24</volume>(
                    <issue>2</issue>):
                    <fpage>33</fpage>–
                    <lpage>46</lpage>.
                    <pub-id pub-id-type="pmid">18568053</pub-id>
                    <issn>0159-8090</issn>
                </mixed-citation>
            </ref>
            <ref id="b50">
                <label>50. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Therapeutisches Drug Monitoring von Cyclosporin A und Tacrolimus – Ergebnisse der Vergleichsmessungen zwischen LCMS und den bisher eingesetzten Immunoassays</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>].
                    <comment>Available from:<uri>http://www.labor-lademannbogen.de/fileadmin/_migrated/content_uploads/TDM-neu_01.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b51">
                <label>51. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>Immunsuppressiva – Therapeutic Drug Monitoring (TDM) mittels LC-MS/MS: Bessere Patientenführung durch exakte Analysenwerte – Cyclosporin A – Tacrolimus – Sirolimus – Everolimus</source>.
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>http://www.labor-lademannbogen.de/fileadmin/_migrated/content_uploads/JUNI0407_01.pdf</uri></comment>.
                </mixed-citation>
            </ref>
            <ref id="b52">
                <label>52. </label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Andrews</surname>
                            <given-names>DJ</given-names>
                        </name>, 
                        <name>
                            <surname>Cramb</surname>
                            <given-names>R</given-names>
                        </name>
                    </person-group>. 
                    <article-title>Cyclosporin: revisions in monitoring guidelines and review of current analytical methods</article-title>. 
                    <source>Ann Clin Biochem</source>. 
                    <year>2002</year>
                    <month>Sep</month>;
                    <volume>39</volume>(
                    <issue>Pt 5</issue>):
                    <fpage>424</fpage>–
                    <lpage>35</lpage>. 
                    <pub-id pub-id-type="doi">10.1258/000456302320314430</pub-id>
                    <pub-id pub-id-type="pmid">12227848</pub-id>
                    <issn>0004-5632</issn>
                </mixed-citation>
            </ref>
            <ref id="b53">
                <label>53. </label>
                <mixed-citation publication-type="webpage">
                    <person-group person-group-type="author"> 
                        <collab></collab>  
                    </person-group>.
                    <source>DoseMe</source>.  
                    [<date-in-citation content-type="access-date" iso-8601-date="2018-01-10">cited 2018 Jan 10</date-in-citation>]. 
                    <comment>Available from:<uri>https://doseme.com.au/</uri></comment>. 
                </mixed-citation>
            </ref>
            <ref id="b54">
                <label>54. </label> 
                <mixed-citation publication-type="journal">  
                    <person-group person-group-type="author">
                        <name>
                            <surname>Saint-Marcoux</surname>
                            <given-names>F</given-names>
                        </name>, 
                        <name>
                            <surname>Marquet</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Jacqz-Aigrain</surname>
                            <given-names>E</given-names>
                        </name>, 
                        <name>
                            <surname>Bernard</surname>
                            <given-names>N</given-names>
                        </name>, 
                        <name>
                            <surname>Thiry</surname>
                            <given-names>P</given-names>
                        </name>, 
                        <name>
                            <surname>Le Meur</surname>
                            <given-names>Y</given-names>
                        </name>, 
                        <etal>et al</etal>
                    </person-group>.
                    <article-title>Patient characteristics influencing ciclosporin pharmacokinetics and accurate Bayesian estimation of ciclosporin exposure in heart, lung and kidney transplant patients</article-title>. 
                    <source>Clin Pharmacokinet</source>. 
                    <year>2006</year>;
                    <volume>45</volume>(
                    <issue>9</issue>):
                    <fpage>905</fpage>–
                    <lpage>22</lpage>. 
                    <pub-id pub-id-type="doi">10.2165/00003088-200645090-00003</pub-id>
                    <pub-id pub-id-type="pmid">16928152</pub-id>
                    <issn>0312-5963</issn>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
</article>

